Brokers and banks usually stop taking bids earlier. Check the exact time with yours.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Purchase of medical equipment for diagnostic centers
Funding capital expenditure for buying and installing medical equipment across existing and proposed diagnostic facilities.
General corporate purposes
Allocating funds for operational flexibility, strategic growth initiatives, and general corporate requirements.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Pramodini Medicare Limited is an established healthcare diagnostic provider headquartered in Vijayawada, Andhra Pradesh. Founded in 2000, the company operates a network of diagnostic facilities offering comprehensive medical testing services across three major divisions: radiology, clinical laboratory, and nuclear medicine. Its radiology offerings include magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, and mammography. The company operates through a hybrid business model combining public-private partnerships (PPP) with state governments, private partnerships with hospitals, and direct-to-consumer standalone diagnostic centers. Its footprint spans multiple centers across 13 cities in India. Additionally, the firm maintains a 24x7 teleradiology command center that provides remote diagnostic reporting for partner facilities. Net proceeds from the fresh equity issue are primarily targeted toward expanding and upgrading diagnostic equipment across existing and newly planned operational centers. The company continues to strengthen its institutional partnership pipeline while scaling up specialized diagnostic modalities such as PET-CT and SPECT imaging.
The company raised 16.06 crore rupees from anchor investors by allocating 13,60,800 equity shares at the upper price band of 118 rupees per share.
Source: RHP • Analysis provided for informational purposes
Last Updated: 17 August 2026, 12:45 PM
Comprehensive diagnostic service spectrum
Offers integrated services across radiology, clinical laboratory, and nuclear medicine under one brand umbrella.
Diversified public-private revenue model
Maintains long-term partnerships with government hospitals and private healthcare entities providing stable institutional volume.
Established regional presence and teleradiology infrastructure
Operates 15 diagnostic centers across 13 cities supported by a centralized 24x7 teleradiology command hub.
High geographic concentration in Andhra Pradesh
A significant portion of operational revenues is derived from facilities located within a single state.
Dependence on government contracts and PPP tenders
Changes in government healthcare policies or non-renewal of public-private partnership contracts could impact operating cash flows.
Capital intensity and equipment obsolescence
Requires continuous capital investment to acquire and maintain advanced medical imaging equipment.
Pramodini Medicare Limited
D.No. 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada - 520002, Andhra Pradesh, India
View on Maps →Purva Sharegistry (India) Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.